ACTIVITIES
Regional Leadership
The quality of production, research and development, and the efficiency of technical and commercial service make Biogénesis Bagó an international leader in animal health and the primary exporter of biotechnological products and veterinary services that provide effective solutions to the main diseases impacting the health and productivity of herds worldwide.
Biogénesis Bagó was the first company in the region to develop: a line of ectoparasiticides, the first vaccine for bovine viral diarrhea, combined vaccines to prevent respiratory and reproductive syndromes in cattle, and obtained the first registration for the Foot-and-Mouth Disease vaccine in 1952 (Argentina).
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
Based on production quality, research and development, and the efficiency of its technical and commercial service, Biogénesis – Bagó has become an international leader in animal health.
The distribution of pharmaceuticals is a key factor of this industry and a competitve advantage of the Bagó Group, with 3 distributors strategically located in Latin America and equipped with state-of-the-art technology.
Victoria Seguros, is a solid and responsible insurance company, with a vast track record and high reputation in the market. It offers a wide range of top quality products.
The pharmochemical production of active pharmaceutical ingredients from chemical inputs is carried out at the Grupo Bagó industrial plant, specifically designed for these types of processes.
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
Based on production quality, research and development, and the efficiency of its technical and commercial service, Biogénesis – Bagó has become an international leader in animal health.
The distribution of pharmaceuticals is a key factor of this industry and a competitve advantage of the Bagó Group, with 3 distributors strategically located in Latin America and equipped with state-of-the-art technology.
Victoria Seguros, is a solid and responsible insurance company, with a vast track record and high reputation in the market. It offers a wide range of top quality products.
The pharmochemical production of active pharmaceutical ingredients from chemical inputs is carried out at the Grupo Bagó industrial plant, specifically designed for these types of processes.
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
